Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Topoisomerase Inhibitors [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
DOXORUBICIN 82,754 15,653 18.9% 28,630 6,923 50.5 yrs 53.9%
ETOPOSIDE 52,603 11,780 22.4% 17,699 5,257 42.5 yrs 41.8%
IRINOTECAN 27,965 4,530 16.2% 10,384 1,656 58.7 yrs 41.4%
EPIRUBICIN 16,274 2,212 13.6% 5,603 1,066 52.8 yrs 86.1%
DAUNORUBICIN 9,852 2,263 23.0% 4,248 1,142 28.7 yrs 46.4%
IDARUBICIN 5,038 1,260 25.0% 1,856 654 44.8 yrs 46.2%
MITOXANTRONE 4,166 995 23.9% 1,556 526 37.0 yrs 48.0%
TOPOTECAN 3,537 773 21.9% 1,213 249 28.7 yrs 51.1%

Head-to-Head Comparisons

DOXORUBICIN vs ETOPOSIDE DOXORUBICIN vs IRINOTECAN DOXORUBICIN vs EPIRUBICIN DOXORUBICIN vs DAUNORUBICIN ETOPOSIDE vs IRINOTECAN ETOPOSIDE vs EPIRUBICIN ETOPOSIDE vs DAUNORUBICIN IRINOTECAN vs EPIRUBICIN IRINOTECAN vs DAUNORUBICIN EPIRUBICIN vs DAUNORUBICIN
← Back to Topoisomerase Inhibitors [MoA] Class side effects →